Programmed Cell Death 2-Like (PDCD2L) Peptid
Kurzübersicht für Programmed Cell Death 2-Like (PDCD2L) Peptid (ABIN938223)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- FACACPGCST GGARSWKVFR SQCLQVPERE AQDAQKQGNS LAAEDWCEGA
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PDCD2 L antibody,
Alternative Names: PDCD2L control peptide, PDCD2L antibody Blocking Peptide, Anti-PDCD2L Blocking Peptide, programmed cell death 2-like Blocking Peptide, MGC13096 Blocking Peptide, PDCD2L, PDCDL-2, PDCDL 2, PDCDL-2 Blocking Peptide, PDCDL 2 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- PDCD2L (Programmed Cell Death 2-Like (PDCD2L))
-
Hintergrund
- Over expression of PDCD2L attenutates TNF-alpha release in Daudi cells. PDCD2L over-expression restrained proliferation of HEK293T cells. DNA/flow cytometry analysis showed that the over-expression of PDCD2L severely delays cell cycle progression at S phase. These all suggest that PDCD2L might play a role in apoptosis.
-
Molekulargewicht
- 39 kDa
Target
-